McKesson Corporation $MCK Stock: Resona Asset Management Co. Ltd. Cuts Position

Resona Asset Management Co. Ltd. lowered its stake in McKesson Corporation (NYSE:MCK – Free Report) by 6.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,030 shares of the company’s stock after selling 2,667 shares during the period. Resona Asset Management Co. Ltd.’s holdings in McKesson were worth $35,111,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Rosenberg Matthew Hamilton increased its stake in shares of McKesson by 2.8% during the third quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company’s stock worth $347,000 after buying an additional 11 shares during the period. Avail Investment Partners LLC raised its holdings in McKesson by 1.7% in the third quarter. Avail Investment Partners LLC now owns 662 shares of the company’s stock valued at $566,000 after acquiring an additional 11 shares in the last quarter. Commonwealth Financial Services LLC lifted its stake in McKesson by 3.8% in the third quarter. Commonwealth Financial Services LLC now owns 304 shares of the company’s stock worth $260,000 after acquiring an additional 11 shares during the last quarter. WealthPLAN Partners LLC lifted its stake in McKesson by 0.4% in the third quarter. WealthPLAN Partners LLC now owns 3,190 shares of the company’s stock worth $2,724,000 after acquiring an additional 12 shares during the last quarter. Finally, Arista Wealth Management LLC lifted its stake in McKesson by 1.0% in the second quarter. Arista Wealth Management LLC now owns 1,446 shares of the company’s stock worth $1,093,000 after acquiring an additional 14 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Stock Up 0.7%

NYSE:MCK opened at $1,069.31 on Friday. The stock’s 50 day moving average price is $974.65 and its 200 day moving average price is $880.71. The company has a market capitalization of $123.46 billion, a PE ratio of 27.50, a P/E/G ratio of 1.87 and a beta of 0.27. McKesson Corporation has a 52-week low of $723.68 and a 52-week high of $1,121.50.

McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, topping the consensus estimate of $10.72 by $0.96. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The company had revenue of $110.96 billion for the quarter, compared to analyst estimates of $109.90 billion. During the same quarter in the previous year, the company posted $9.86 earnings per share. The firm’s revenue was up 7.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that McKesson Corporation will post 46.09 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be given a $0.94 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is 9.67%.

Insider Buying and Selling at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the firm’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares of the company’s stock, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 650 shares of McKesson stock in a transaction on Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total transaction of $716,924.00. Following the completion of the transaction, the executive vice president owned 4,414 shares in the company, valued at approximately $4,868,465.44. This represents a 12.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,161 shares of company stock valued at $2,242,515. 0.06% of the stock is owned by insiders.

Recent McKesson Headlines

Investors following MCK have been watching these headlines:

Wall Street Analysts Forecast Growth

MCK has been the subject of several analyst reports. Wells Fargo & Company boosted their price target on shares of McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 11th. Bank of America raised their price objective on shares of McKesson from $950.00 to $1,050.00 in a report on Thursday, August 6th. Evercore restated an “outperform” rating and issued a $950.00 price objective (down from $1,000.00) on shares of McKesson in a report on Thursday, August 6th. Mizuho lifted their price objective on shares of McKesson from $905.00 to $1,020.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 20th. Finally, UBS Group boosted their target price on shares of McKesson from $1,200.00 to $1,250.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and an average target price of $1,054.12.

Get Our Latest Stock Analysis on McKesson

McKesson Profile

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

Further Reading

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.